Hospital Interns Psychological State During the COVID-19 (RESICOV)

Hospital Interns Psychological State During the COVID-19 Pandemic

The mental health of the French population in response to covid-19 pandemic is of concern.

Health professionals are prone to more mental disorders due to their direct exposure to the pandemic consequences. Indeed, compared to general population, health care workers face enormous in the current health situation, especially those who may be in contact with suspected or confirmed cases (risk of infection, inadequate protection, loss of control, lack of experience in managing the diseases, overwork, stigma, lack of support). Thus, it seems interesting to describe the psychological state of hospital interns during this pandemic.

Study Overview

• Status: Completed
• Conditions: Depression; Stress Disorders, Post-Traumatic; COVID 19

• Study Type: Observational
• Enrollment (Actual): 102

Contacts and Locations

Study Locations

• France
  • Montpellier, France, 34295
    • University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Occitanie-Est hospital interns

Description

Inclusion criteria:

• Being a DES intern (Occitanie-Est)
• Being on internship as of November 1, 2020

Exclusion criteria:

- Refusal to participate

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depressive Symptomatology (PHQ-9)	evaluation of the participant depressive symptomatology based on the PHQ-9 scale. The PHQ-9 total score ranges from 0 to 27. A score between 0 and 4 indicates absence of depression; a score between 5 and 9 indicates mild depression; a score between 10 and 14 indicates moderate depression; score between 15 and 19 indicates moderately severe depression and score between 20 and 27 indicates sever depression.	at 5 months (6 months of internship)
Depressive Symptomatology (PHQ-9)	evaluation of the participant depressive symptomatology based on the PHQ-9 scale. The PHQ-9 total score ranges from 0 to 27. A score between 0 and 4 indicates absence of depression; a score between 5 and 9 indicates mild depression; a score between 10 and 14 indicates moderate depression; score between 15 and 19 indicates moderately severe depression and score between 20 and 27 indicates sever depression.	at inclusion (1 month of internship)
Depressive Symptomatology (PHQ-9)	evaluation of the participant depressive symptomatology based on the PHQ-9 scale. The PHQ-9 total score ranges from 0 to 27. A score between 0 and 4 indicates absence of depression; a score between 5 and 9 indicates mild depression; a score between 10 and 14 indicates moderate depression; score between 15 and 19 indicates moderately severe depression and score between 20 and 27 indicates sever depression.	at 2 months (3 months of internship)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Sleep evaluation with the Insomnia Severity Index (ISI)	sleep quality evaluation based on the ISI score. The ISI total score ranges from 0 to 28. A score between 0 and 7 indicates an absence of insomnia; a score between 8 and 14 indicates sub-threshold insomnia; a score between 15 and 21 indicates moderate insomnia and a score between 22 and 28 indicates severe insomnia.	at inclusion (1 month of internship)
Sleep evaluation with the Insomnia Severity Index (ISI)	sleep quality evaluation based on the ISI score. The ISI total score ranges from 0 to 28. A score between 0 and 7 indicates an absence of insomnia; a score between 8 and 14 indicates sub-threshold insomnia; a score between 15 and 21 indicates moderate insomnia and a score between 22 and 28 indicates severe insomnia.	at 2 months (3 months of internship)
Sleep evaluation with the Insomnia Severity Index (ISI)	sleep quality evaluation based on the ISI score. The ISI total score ranges from 0 to 28. A score between 0 and 7 indicates an absence of insomnia; a score between 8 and 14 indicates sub-threshold insomnia; a score between 15 and 21 indicates moderate insomnia and a score between 22 and 28 indicates severe insomnia.	at 5 months (6 months of internship)
Anxiety with the Generalised Anxiety Disorder Assessment (GAD-7)	anxiety evaluation based on the GAD-7 score. The GAD-7 total score ranges from 0 to 21. Scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety, respectively.	at inclusion (1 month of internship)
Anxiety with the Generalised Anxiety Disorder Assessment (GAD-7)	anxiety evaluation based on the GAD-7 score. The GAD-7 total score ranges from 0 to 21. Scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety, respectively.	at 2 months (3 months of internship)
Anxiety with the Generalised Anxiety Disorder Assessment (GAD-7)	anxiety evaluation based on the GAD-7 score. The GAD-7 total score ranges from 0 to 21. Scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety, respectively.	at 5 months (6 months of internship)
Psychological pain assessed with visual analogue scale (VAS)	assessment of the psychological pain. The VAS ranges from 0 (none) to 10 (maximum pain).	at inclusion (1 month of internship)
Psychological pain assessed with visual analogue scale (VAS)	assessment of the psychological pain. The VAS ranges from 0 (none) to 10 (maximum pain).	at 2 months (3 months of internship)
Psychological pain assessed with visual analogue scale (VAS)	assessment of the psychological pain. The VAS ranges from 0 (none) to 10 (maximum pain).	at 5 months (6 months of internship)
Physical pain assessed with visual analogue scale (VAS)	assessment of the physical pain. The VAS ranges from 0 (none) to 10 (maximum pain).	at inclusion (1 month of internship)
Physical pain assessed with visual analogue scale (VAS)	assessment of the physical pain. The VAS ranges from 0 (none) to 10 (maximum pain).	at 2 months (3 months of internship)
Physical pain assessed with visual analogue scale (VAS)	assessment of the physical pain. The VAS ranges from 0 (none) to 10 (maximum pain).	at 5 months (6 months of internship)
Suicidal ideation assessed with visual analogue scale (VAS)	assessment of the suicidal ideation. The VAS ranges from 0 (none) to 10 (maximum ideation).	at inclusion (1 month of internship)
Suicidal ideation assessed with visual analogue scale (VAS)	assessment of the suicidal ideation. The VAS ranges from 0 (none) to 10 (maximum ideation).	at 2 months (3 months of internship)
Suicidal ideation assessed with visual analogue scale (VAS)	assessment of the suicidal ideation. The VAS ranges from 0 (none) to 10 (maximum ideation).	at 5 months (6 months of internship)
Anger assessed with the State Anger Expression Inventory (STAXI - state)	anger assessment with the STAXI state scale. The total score ranges from 0 to 50. The higher the score the higher the anger expression.	at 2 months (3 months of internship)
Anger assessed with the State Anger Expression Inventory (STAXI - state)	anger assessment with the STAXI state scale. The total score ranges from 0 to 50. The higher the score the higher the anger expression.	at 5 months (6 months of internship)
Anger assessed with the State Anger Expression Inventory (STAXI - state)	anger assessment with the STAXI state scale. The total score ranges from 0 to 50. The higher the score the higher the anger expression.	at inclusion (1 month of internship)
Stressful Event Impact (Horowitz scale)	assessement of stressful event impact with the Horowitz scale. The total score ranges from 0 to 45. The higher the score the higher the trauma	at inclusion (1 month of internship)
Stressful Event Impact (Horowitz scale)	assessement of stressful event impact with the Horowitz scale. The total score ranges from 0 to 45. The higher the score the higher the trauma	at 2 months (3 months of internship)
Stressful Event Impact (Horowitz scale)	assessement of stressful event impact with the Horowitz scale. The total score ranges from 0 to 45. The higher the score the higher the trauma	at 5 months (6 months of internship)
Psychotropic drugs use	assessement of the psychotropic drugs use increase	at inclusion (1 month of internship)
Psychotropic drugs use	assessement of the psychotropic drugs use increase	at 5 months (6 months of internship)
Psychotropic drugs use	assessement of the psychotropic drugs use increase	at 2 months (3 months of internship)
Tobacco consumption	assessement of the tobacco consumption increase	at 2 months (3 months of internship)
Tobacco consumption	assessement of the tobacco consumption increase	at inclusion (1 month of internship)
Tobacco consumption	assessement of the tobacco consumption increase	at 5 months (6 months of internship)
Alcohol consumption	assessement of the alcohol consumption increase	at 2 months (3 months of internship)
Alcohol consumption	assessement of the alcohol consumption increase	at inclusion (1 month of internship)
Alcohol consumption	assessement of the alcohol consumption increase	at 5 months (6 months of internship)
Illicit substances use	assessement of the illicit substances use increase	at inclusion (1 month of internship)
Illicit substances use	assessement of the illicit substances use increase	at 2 months (3 months of internship)
Illicit substances use	assessement of the illicit substances use increase	at 5 months (6 months of internship)

Collaborators and Investigators

• Sponsor: University Hospital, Montpellier
• Investigators: Study Director: Emilie Olie, MD PhD, University Hospital, Montpellier

Study record dates

Study Major Dates

• Study Start (Actual): December 1, 2020
• Primary Completion (Actual): May 30, 2021
• Study Completion (Actual): July 30, 2021

Study Registration Dates

• First Submitted: December 14, 2020
• First Submitted That Met QC Criteria: December 14, 2020
• First Posted (Actual): December 16, 2020

Study Record Updates

• Last Update Posted (Actual): October 25, 2021
• Last Update Submitted That Met QC Criteria: October 22, 2021
• Last Verified: October 1, 2021

More Information

Terms related to this study

• Keywords: Hospital interns
• Additional Relevant MeSH Terms: Mental Disorders; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; Trauma and Stressor Related Disorders; Stress Disorders, Traumatic; COVID-19; Stress Disorders, Post-Traumatic
• Other Study ID Numbers: RECHMPL20_0665

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: NC

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No